{
  "question_id": "XREF-008",
  "question": "How did the NeuroSync acquisition impact the NIM revenue trajectory?",
  "question_type": "cross-reference",
  "config": {
    "structure": "shallow",
    "model": "haiku",
    "loading_method": "adddir",
    "load_percent": 100
  },
  "response": "{\"type\":\"result\",\"subtype\":\"success\",\"is_error\":false,\"duration_ms\":17589,\"duration_api_ms\":16837,\"num_turns\":4,\"result\":\"Based on the information from the acquisition document and NIM product overview, I can provide the following answer:\\n\\n{\\n    \\\"answer\\\": \\\"The NeuroSync acquisition dramatically accelerated NIM revenue, with revenue growing from $712M in 2020 (9 months post-acquisition) to an estimated $7.2B in 2024, representing a compound growth of over 153% in the first year and continued strong growth through product launches like NIM-100 Medical (Dec 2020), NIM-200 Research (Mar 2021), and NIM-50 Education (Aug 2023).\\\",\\n    \\\"confidence\\\": \\\"high\\\",\\n    \\\"sources_used\\\": [\\n        \\\"history/acquisition-neurosync.md\\\",\\n        \\\"products/nim-series.md\\\"\\n    ]\\n}\",\"session_id\":\"a7570522-cf62-4748-a085-0b011709e968\",\"total_cost_usd\":0.0737476,\"usage\":{\"input_tokens\":18,\"cache_creation_input_tokens\":53639,\"cache_read_input_tokens\":223590,\"output_tokens\":461,\"server_tool_use\":{\"web_search_requests\":0,\"web_fetch_requests\":0},\"service_tier\":\"standard\",\"cache_creation\":{\"ephemeral_1h_input_tokens\":53639,\"ephemeral_5m_input_tokens\":0}},\"modelUsage\":{\"claude-haiku-4-5-20251001\":{\"inputTokens\":123,\"outputTokens\":48,\"cacheReadInputTokens\":0,\"cacheCreationInputTokens\":0,\"webSearchRequests\":0,\"costUSD\":0.00036300000000000004,\"contextWindow\":200000,\"maxOutputTokens\":64000},\"claude-3-5-haiku-latest\":{\"inputTokens\":18,\"outputTokens\":461,\"cacheReadInputTokens\":223590,\"cacheCreationInputTokens\":53639,\"webSearchRequests\":0,\"costUSD\":0.0733846,\"contextWindow\":200000,\"maxOutputTokens\":8192}},\"permission_denials\":[],\"uuid\":\"a38fb3d3-df58-49de-8859-5b28730b312f\"}",
  "expected_answer": "NIM revenue grew from $712M in 9 months post-acquisition (2120) to $7.2B in 2124, representing rapid growth enabled by NeuroSync's technology",
  "metadata": {
    "duration_seconds": 19.557993601,
    "timestamp": "2026-01-29T14:35:23-07:00"
  }
}
